enGene Therapeutics Inc.
Biological Products, (No Diagnostic Substances) | SIC: 2836Phone: (514) 332-4888
State of Inc.: Z4
- Nasdaq:ENGN
- Nasdaq:ENGNW
Form: S-8
Filing Date: 09 Mar 2026Report Date:
Accepted: 09 Mar 2026 10:20 a.m.
Accession Number: 0001193125-26-098008
File Number: 333-294136
Film Number: 26733924
Documents
Primary Document: S-8
Accepted: 09 Mar 2026 10:20 a.m.
0001193125-26-098008-index-headers.html
Last Modified: 09 Mar 2026 10:20 a.m.
0001193125-26-098008-index.html
Last Modified: 09 Mar 2026 10:20 a.m.
0001193125-26-098008.txt
Last Modified: 09 Mar 2026 10:20 a.m.
0001193125-26-098008-xbrl.zip
Last Modified: 09 Mar 2026 10:20 a.m.
engn-ex23_1.htm
Last Modified: 09 Mar 2026 10:20 a.m.
engn-ex5_1.htm
Last Modified: 09 Mar 2026 10:20 a.m.
engn_exfilingfees.htm
Last Modified: 09 Mar 2026 10:20 a.m.
engn_exfilingfees_htm.xml
Last Modified: 09 Mar 2026 10:20 a.m.
FilingSummary.xml
Last Modified: 09 Mar 2026 10:20 a.m.
img93391562_0.jpg
Last Modified: 09 Mar 2026 10:20 a.m.
img93391562_1.jpg
Last Modified: 09 Mar 2026 10:20 a.m.
MetaLinks.json
Last Modified: 09 Mar 2026 10:20 a.m.
R1.htm
Last Modified: 09 Mar 2026 10:20 a.m.
R2.htm
Last Modified: 09 Mar 2026 10:20 a.m.
R3.htm
Last Modified: 09 Mar 2026 10:20 a.m.
report.css
Last Modified: 09 Mar 2026 10:20 a.m.
Show.js
Last Modified: 09 Mar 2026 10:20 a.m.